EOLS · Evolus, Inc.
$6.02
-0.01 (-0.17%)
At close · Jul 30
Market Cap
$397.10M
Shares
65.85M
Evolus, Inc. Earnings Call Transcripts
Every quarterly earnings call for Evolus, Inc. (EOLS) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲27.1%
$33.90M
−$20.28M
'22 Q3
22-11-08
▲25.9%
$43.65M
−$13.16M
'22 Q4
23-01-30
▲23%
$41.72M
−$14.79M
'23 Q1
23-05-09
▲32.8%
$49.35M
−$18.14M
'23 Q2
23-08-02
▲47.6%
$50.02M
−$16.92M
'23 Q3
23-11-07
▲39.8%
$61.00M
−$11.83M
'23 Q4
24-03-07
▲42.2%
$59.33M
−$13.11M
'24 Q1
24-05-07
▲35.6%
$66.91M
−$11.35M
'24 Q2
24-07-31
▲22.1%
$61.09M
−$19.17M
'24 Q3
24-11-06
▲29.4%
$78.95M
−$6.79M
'24 Q4
25-03-04
▲15.5%
$68.52M
−$18.89M
'25 Q1
25-05-07
▲3.7%
$69.39M
−$17.14M
'25 Q2
25-08-05
▲12.9%
$68.97M
−$15.74M
'25 Q3
25-11-05
▲14.4%
$90.30M
$130,000
'25 Q4
26-03-03
LATEST
▲6.7%
$73.14M
−$10.67M
'26 Q1
26-05-04
Earnings call
FY26 · Q2
2026-08-05
Q2 2026 Evolus, Inc. Earnings Conference Call
Scheduled
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-04
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-04
Evolus, Inc. Q1 FY2026 Earnings Call
Confident tone
International Expansion / Esteem Europe Launch
Aesthetics Market Conditions
Skulpt/Sculpt FDA Approval
Revenue
$73.14M
▲ 6.7% YoY Diluted EPS
$-0.16
Gross margin
66.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-04-14
Needham Virtual Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-03-03
Evolus, Inc. Q4 FY2025 Earnings Call
Confident tone
Evolysse filler launch and expansion
International expansion
Jeuveau U.S. market share gains
Revenue
$90.30M*
▲ 14.4% YoY Gross margin
65.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-05
Evolus, Inc. Q3 FY2025 Earnings Call
Positive tone
Evolysse product launch and adoption
Jeuveau performance and market share
Path to profitability and expense discipline
Revenue
$68.97M
▲ 12.9% YoY Diluted EPS
$-0.24
Gross margin
66.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Evolus, Inc. Q2 FY2025 Earnings Call
Cautious tone
U.S. toxin market softness
Evolysse launch
2025 guidance reset
Revenue
$69.39M
▲ 3.7% YoY Diluted EPS
$-0.27
Gross margin
65.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Evolus, Inc. Q1 FY2025 Earnings Call
Confident tone
Evolysse launch momentum
Tariff exposure and mitigation
Toxin (Jeuveau) commercial performance
Revenue
$68.52M
▲ 15.5% YoY Diluted EPS
$-0.30
Gross margin
68.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-04
Evolus, Inc. Q4 FY2024 Earnings Call
Confident tone
Evolys Launch
Profitability
Jeuveau
Revenue
$78.95M*
▲ 29.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-06
Evolus, Inc. Q3 FY2024 Earnings Call
Confident tone
Evolysse / Estyme Filler Launch
Revenue Growth & Market Outperformance
Profitability Path
Revenue
$61.09M
▲ 22.1% YoY Diluted EPS
$-0.30
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-31
Evolus, Inc. Q2 FY2024 Earnings Call
Confident tone
Revenue growth and market share
Filler pipeline (Evolysse / Athene)
Aesthetic market dynamics and GLP impact
Revenue
$66.91M
▲ 35.6% YoY Diluted EPS
$-0.18
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Evolus, Inc. Q1 FY2024 Earnings Call
Confident tone
Jeuveau / Nuceiva Neurotoxin Business
Long-Term Revenue Target
Path to Profitability
Revenue
$59.33M
▲ 42.2% YoY Diluted EPS
$-0.22
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-07
Evolus, Inc. Q4 FY2023 Earnings Call
Confident tone
Path to profitability
Evolysse/Estyme dermal filler expansion
International/global expansion
Revenue
$61.00M*
▲ 39.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Evolus, Inc. Q3 FY2023 Earnings Call
Revenue
$50.02M
▲ 47.6% YoY Diluted EPS
$-0.30
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-02
Evolus, Inc. Q2 FY2023 Earnings Call
Revenue
$49.35M
▲ 32.8% YoY Diluted EPS
$-0.32
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Evolus, Inc. Q1 FY2023 Earnings Call
Revenue
$41.72M
▲ 23% YoY Diluted EPS
$-0.26
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-30
Evolus, Inc. Q4 FY2022 Earnings Call
Revenue
$43.65M*
▲ 25.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Evolus, Inc. Q3 FY2022 Earnings Call
Revenue
$33.90M
▲ 27.1% YoY Diluted EPS
$-0.36
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-02
Evolus, Inc. Q2 FY2022 Earnings Call
Revenue
$37.16M
▲ 42.4% YoY Diluted EPS
$-0.42
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
Evolus, Inc. Q1 FY2022 Earnings Call
Revenue
$33.91M
▲ 177% YoY Diluted EPS
$-0.31
▼ 293.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-03
Evolus, Inc. Q4 FY2021 Earnings Call
Revenue
$34.66M*
▲ 68.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-02
Evolus, Inc. Q3 FY2021 Earnings Call
Revenue
$26.68M
▲ 51.1% YoY Diluted EPS
$-0.35
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
Evolus, Inc. Q2 FY2021 Earnings Call
Revenue
$26.10M
▲ 234.3% YoY Diluted EPS
$-0.31
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-26
Evolus, Inc. Q1 FY2021 Earnings Call
Revenue
$12.24M
▲ 16.6% YoY Diluted EPS
$0.16
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-01-05
Evolus, Inc. Q4 FY2020 Earnings Call
Revenue
$20.58M*
Rev · 5q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-29
Evolus, Inc. Q3 FY2020 Earnings Call
Revenue
$17.66M
▲ 34.1% YoY Gross margin
72.5%
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-10
Evolus, Inc. Q2 FY2020 Earnings Call
Revenue
$7.81M
▲ 237.8% YoY Gross margin
75.0%
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-16
Evolus, Inc. Q1 FY2020 Earnings Call
Revenue
$10.50M
Gross margin
59.8%
Rev · 3q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-25
Evolus, Inc. Q4 FY2019 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–29 of 29 earnings calls
Key facts
CIK
1570562
CUSIP
30052C107
13F (30d)
24 filings
24 filers
Visit website
Investor relations